China imports more than 600 million US dollars of natural botanicals every year

At present, the annual sales volume of the world botanical medicine market is about 16 billion US dollars, and the annual growth rate is 10% to 20% As a big country of traditional Chinese medicine, China's annual export of traditional Chinese medicine is only about US $100 million, while the import of natural plant medicine has exceeded US $600 million, and the import volume has far exceeded the export volume This is the figure disclosed by Zou Zhongquan, vice president of China Pharmaceutical Quality Management Association on Friday He said in the "International Summit Forum on traditional Chinese herbal preparations" held here that the reason why China's import of proprietary Chinese medicine is still growing is that western countries have started to take the research and development of natural drugs dominated by traditional Chinese medicine as a strategic industry to promote the internationalization of traditional Chinese medicine In recent years, many multinational Biopharmaceutical Enterprises have expanded their investment in China and have invested in China There is a huge pressure on pharmaceutical enterprises Zhang Heyong, consultant of the State Food and Drug Administration and President of China Pharmaceutical Quality Management Association, believes that with the acceleration of economic globalization, the international community has become more and more receptive to traditional medicine At present, more than 70 countries in the world have formulated herbal laws and regulations, and more than 120 countries and regions have established various types of traditional medicine institutions, which has driven the growth of Chinese herbal medicine demand 。 At present, in addition to the strong demand in Southeast Asia, the traditional medicine market in North America, Western Europe, Africa and the Arab region is also gradually expanding According to the data provided by him, the annual sales of Chinese herbal medicines in the international market account for about 20% of the drug sales, most of which are products from Europe, Japan and other countries, while China only accounts for less than 10% of the global market share of herbal medicines He believed that traditional Chinese medicine, which is accepted by all countries, must have the terminology, testing methods and quality control standards in line with the international common use Zhang Heyong disclosed that the "zhimingde Wuqing Tongti oral liquid" developed by Chinese experts using modern quantum technology has successively obtained the approval certificate of therapeutic drugs from Australian and Singapore governments this year, and passed the test of the US Food and Drug Administration last month, obtaining the sales certificate, providing successful experience for promoting the entry of Chinese traditional medicine into the international market.